• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » ESCMID calls for national infection control committees

ESCMID calls for national infection control committees

November 13, 2015
CenterWatch Staff

The European Society of Clinical Microbiology and Infectious Disease (ESCMID), a nonprofit organization that explores the risks and best practices in infectious disease, has in recent years been very active in the area of antimicrobial resistance. It is now calling on individual European nations to join its battle.

Several of the society’s study groups focus on developing strategies and policies to tackle the problem and the society supports many European and international initiatives. Most noteworthy is its role in setting up the European Committee on Antimicrobial Susceptibility Testing (EUCAST), which determines breakpoints for bacteria and fungi for existing and new antimicrobial agents.

Earlier this year, ESCMID introduced the European Committee on Infection Control (EUCIC), which aims to increase harmonization of infection control and prevention measures across Europe using education, training goals, guidelines and political awareness. Already, it has accounted for more than 50% of European countries (including Sweden, Spain, Germany, Italy and the U.K.), and it is now asking for national representation to come forward from each of the remaining countries.

EUCIC is further calling on professionals from European countries to help create national committees, the major goal of which is to provide its advisory board with relevant networks within each country. EUCIC’s objective is to create a new infection, control and prevention (IPC) network based on extensive partnerships among European national representatives and the most relevant societies in the field of infection control, infectious diseases and clinical microbiology.

Professor Evelina Tacconelli of Universitätsklinikum Tübingen in Germany, who is chair of EUCIC, said, “It’s a really exciting time with the new group having formed, and we are now actively seeking out representatives from the remaining European nations to start projects in collaboration with international stakeholders, as well as other ESCMID groups working on infection control and preventive measures. Ultimately, the group and collaborations will contribute to harmonize infection control across Europe through increased educational and training tools and new guidance documents.”

The ESCMID Study Group for Antibiotic Policies (ESGAP) currently is finishing a European-wide survey on the “teaching on prudent antibiotic prescribing” among final-year medical students. More than 10,000 have participated, and the results will be announced at ECCMID 2016. The study group is now calling on junior doctors throughout Europe to take part in a study on antibiotic prescribing and resistance. Evaluating cross-country trends will provide the information necessary to improve clinical practice and help mitigate the growth of antimicrobial resistance.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing